Risk of cardiovascular disease in essential hypertension. The PIUMA study. Hypertension 2000, 36:1072?078. Li Q, Yang Z, Lu B, Wen J, Ye Z, Chen L, He M, Tao X, Zhang W, Huang Y, Zhang Z, Qu S, Hu R: PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/26780312 Serum uric acid level and its association with metabolic syndrome and carotid atherosclerosis in patients with type 2 diabetes. Cardiovasc Diabetol 2011, 10:72. Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA: purchase Anlotinib Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 2010, 62:170?80. Culleton BF, Larson MG, Kannel WB, Levy D: Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 1999, 131:7?3. Brand FN, McGee DL, Kannel WB, Stokes J 3rd, Castelli WP: Hyperuricemia as a risk factor of coronary heart disease: The Framingham Study. Am J Epidemiol 1985, 121:11?8. Moriarity JT, Folsom AR, Iribarren C, Nieto FJ, Rosamond WD: Serum uric acid and risk of coronary heart disease: Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol 2000, 10:136?43. Guidelines for data processing and analysis of the International Physical Activity Questionnaire (IPAQ). 2006. Available at: http://www.ipaq.ki.se/. WHO/MONICA-Project: Multinational Monitoring of Trends andDeterminants in Cardiovascular Diseases (MONICA Project) and Manual of Operation. Geneva, Switzerland: World Health Organization, Cardiovascular Disease Unit; 1983. Liu J, Grundy SM, Wang W, Smith SC, Vega GL, Wu Z, Zeng Z, Wang W, Zhao D: Ethnic-Specific Criteria for the Metabolic Syndrome. Diabetes Care 2006, 29:1414?416. Takayama S, Kawamoto R, Kusunoki T, Abe M, Onji M: Uric acid is an independent risk factor for carotid atherosclerosis in a Japanese elderly population without metabolic syndrome. Cardiovasc Diabetol 2012, 11:2. Perlstein TS, Gumieniak O, Williams GH, Sparrow D, Vokonas PS, Gaziano M, Weiss ST, Litonjua AA: Uric acid and the development of hypertension: the normative aging study. Hypertension 2006, 48:1031?036. Shankar A, Klein R, Klein BE, Nieto FJ: The association between serum uric acid level and long-term incidence of hypertension: Population-based cohort study. J Hum Hypertens 2006, 20:937?45. Masuo K, Kawaguchi H, Mikami H, Ogihara T, Tuck ML: Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 2003, 42:474?80. Nakanishi N, Okamoto M, Yoshida H, Matsuo Y, Suzuki K, Tatara K: Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers. Eur J Epidemiol 2003, 18:523?30. Dehghan A, Van Hoek M, Sijbrands EJ, Hofman A, Witteman JC: High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care 2008, 31:361?62. Rathmann W, Funkhouser E, Dyer AR, Roseman JM: Relations of hyperuricemia with the various components of the insulin resistance syndrome in young black and white adults: the CARDIA study. Coronary Artery Risk Development in Young Adults. Ann Epidemiol 1998, 8:250?61. Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, Krotova K, Block ER, Prabhakar S, Johnson RJ: Hyperuricemia induces endothelial dysfunction. Kidney Int 2005, 67:1739?742. Iseki K, Ikemiya Y, Inoue T, Iseki C, Kinjo K, Takishita S: Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis 2004, 44:642?50. Davies KJ, Sevanian A, Muakkassah-Kelly SF, Hochstein P: Ur.